Genprex Total Stockholder Equity from 2010 to 2024

GNPX Stock  USD 1.09  0.01  0.91%   
Genprex Total Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Total Stockholder Equity is likely to outpace its year average in 2024. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
2015-12-31
Previous Quarter
4.3 M
Current Value
1.7 M
Quarterly Volatility
15.5 M
 
Yuan Drop
 
Covid
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.61. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
  
Check out the analysis of Genprex Correlation against competitors.
For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Latest Genprex's Total Stockholder Equity Growth Pattern

Below is the plot of the Total Stockholder Equity of Genprex over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Genprex's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
Total Stockholder Equity10 Years Trend
Slightly volatile
   Total Stockholder Equity   
       Timeline  

Genprex Total Stockholder Equity Regression Statistics

Arithmetic Mean8,827,455
Geometric Mean2,262,720
Coefficient Of Variation146.32
Mean Deviation9,789,168
Median1,624,868
Standard Deviation12,916,011
Sample Variance166.8T
Range40.9M
R-Value0.64
Mean Square Error106.6T
R-Squared0.41
Significance0.01
Slope1,842,317
Total Sum of Squares2335.5T

Genprex Total Stockholder Equity History

202414.2 M
20237.4 M
202222.3 M
202141.3 M
202030.9 M
2019M
20188.9 M

About Genprex Financial Statements

Genprex investors use historical fundamental indicators, such as Genprex's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Stockholder Equity7.4 M14.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.